FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

518 letters match. Newest first.

  1. XO Biologix, LLC

    XO Biologix markets MaviX, an amniotic-fluid product, as an unapproved new drug and unlicensed biologic.

    High risk
  2. Prime Vitality, Inc. dba Prime Peptides

    FDA warned Prime Peptides that its website sells Semaglutide and Retatrutide as unapproved new drugs for weight loss and diabetes.

    High risk
  3. Swisschems

    Swisschems sells Semaglutide and Retatrutide as unapproved new drugs despite research-chemical labeling.

    High risk
  4. Xcel Research LLC

    FDA warned Xcel Research for selling unapproved peptide drugs online with human-use claims.

    High risk
  5. Summit Research Peptides

    FDA warned Summit Research Peptides for selling unapproved semaglutide, retatrutide, cagrilintide, tirzepatide, and mazdutide with drug claims.

    High risk
  6. Veronvy

    FDA warned Veronvy that its Elily Veronvy weight-loss drops are unapproved new drugs and falsely labeled "FDA APPROVED."

    Medium
  7. Dr. Brite, LLC

    FDA cited Dr. Brite for manufacturing quality failures and selling unapproved, misbranded oral care and hand sanitizer drugs.

    High risk
  8. LCC Ltd.

    FDA warned LCC Ltd. over manufacturing-quality failures, contamination testing gaps, discarded lab data, and unapproved mouthwash drugs.

    High risk
  9. Fancy Drops Beauty LLC

    FDA says Fancy Drops Beauty sells unapproved eye drops claimed to change eye color.

    High risk
  10. Pinnacle Transplant Technologies, LLC

    FDA warns Pinnacle Transplant Technologies over unapproved injectable amniotic products and sterility CGMP failures.

    High risk
  11. Amnio Technology, LLC

    FDA warned Amnio Technology over unapproved injectable amniotic products and serious manufacturing deviations at its Phoenix facility.

    High risk
  12. Mexicanrxpharm.com

    FDA told Mexicanrxpharm.com to stop selling unapproved, misbranded opioid pain drugs to U.S. consumers online.

    High risk
  13. Little Moon Essentials, LLC

    FDA warns Little Moon Essentials over CGMP failures and unapproved topical analgesic drugs made in Dania Beach, Florida.

    High risk
  14. Far East Summit LLC

    FDA says Far East Summit sold herbal supplements as unapproved drugs and made them under serious manufacturing violations.

    High risk
  15. Azurity Pharmaceuticals, Inc.

    FDA warned Azurity Pharmaceuticals over unapproved FIRST drug kits and manufacturing quality failures at its Wilmington, MA plant.

    High risk
  16. Nomida.biz

    FDA warned Nomida.biz over its website selling unapproved and misbranded semaglutide and tirzepatide drugs to U.S. consumers.

    High risk
  17. Quality CDMO, Inc.

    FDA warned Quality CDMO that its prescription skin and scalp drugs are unapproved and lack FDA-approved applications.

    High risk
  18. Root Bioscience Brands, LLC dba Naternal

    FDA warned Naternal that its CBD oils, gummies, and pet hemp oil are unapproved drugs due to drug claims.

    High risk
  19. Regenerative Processing Plant, LLC

    FDA warns Regenerative Processing Plant over unapproved, misbranded Regener-Eyes eye drops and serious sterile manufacturing violations.

    High risk
  20. MexHealth LLC d/b/a Al Natural E-Shop

    FDA warned MexHealth LLC d/b/a Al Natural E-Shop that its Ossos-Sans supplement is an unapproved, misbranded drug containing hidden diclofenac and methocarbamol.

    High risk
  21. SoloVital

    FDA says SoloVital's Umary supplement is an unapproved, misbranded drug containing hidden diclofenac and omeprazole.

    High risk
  22. Everymarket Inc.

    FDA warned Everymarket Inc. that its website sells two unapproved drugs, one with hidden dexamethasone and chlorpheniramine.

    High risk
  23. Berkeley Biologics, LLC, previously operating as Elutia, Inc. – Orthobiologics Business Unit, formerly Aziyo Biologics, Inc.

    FDA says Berkeley Biologics' viable bone matrix products are unapproved drugs, with donor screening failures tied to tuberculosis infections.

    High risk
  24. Central Admixture Pharmacy Services, Inc.

    FDA warns Central Admixture Pharmacy Services over sterile compounded drugs, contamination risks, and quality failures at its San Diego site.

    High risk
  25. Walmart, Inc.

    FDA warned Walmart over selling an unapproved 90% lactic acid chemical peel drug that can cause burns.

    High risk
  26. ISIS.GOLD

    ISIS.GOLD sells TCA 100% and Whitening SA chemical peels as unapproved new drugs without FDA-approved applications.

    High risk
  27. Skin Beauty Solutions

    FDA warns Skin Beauty Solutions that its chemical peel products are unapproved new drugs sold with acne and scar treatment claims.

    High risk
  28. Repare Skincare

    Repare Skincare sold unapproved TCA and glycolic acid chemical peels online with drug claims, FDA says.

    High risk
  29. Matte Beauty

    FDA warned Matte Beauty that its chemical peel drugs are unapproved and sold with treatment claims.

    High risk
  30. Amazon.com, Inc.

    FDA warns Amazon over selling two unapproved chemical peel drugs that can burn skin.

    High risk
  31. V10Suppliers.com

    FDA warned UK website V10Suppliers.com for selling unapproved, misbranded opioid drugs to U.S. consumers.

    High risk
  32. White Label Leaf, LLC/Flying Monkey US, LLC

    FDA warned Flying Monkey US that its Delta-8 THC gummies are adulterated food and are being sold as unapproved new drugs.

    High risk
  33. Cholrem Pty Ltd dba Cholrem and Cholrem Pharmaceuticals

    FDA warned Cholrem over selling unapproved RemChol enema products with claims to treat atherosclerosis and reverse heart disease.

    High risk
  34. ARG Laboratories, Inc.

    FDA found ARG Laboratories released failing over-the-counter drug lots, lacked manufacturing controls, and marketed two unapproved pain creams.

    High risk
  35. Natural Ginger, Corp/Jonaus Corp

    FDA warned Natural Ginger that it markets six syrups and supplements as unapproved new drugs with disease-treatment claims on its website.

    Medium
  36. Laboratorio Magnachem International

    FDA cited Laboratorio Magnachem for CGMP failures and unapproved, misbranded Broncochem cough/cold drugs after a 2023 inspection.

    High risk
  37. Premier Manufacturing Products, LLC

    FDA warns Premier Manufacturing over Tianaa tianeptine products sold as unapproved new drugs.

    High risk
  38. Cosmetic Solutions, LLC

    FDA warns Cosmetic Solutions over manufacturing failures and unapproved OTC drugs at Boca Raton plant.

    High risk
  39. Ward Smelling Salts

    FDA warns Canadian maker Ward Smelling Salts that its ammonia inhalant products are unapproved new drugs sold illegally in the U.S.

    High risk
  40. APG SEVEN, INC

    FDA warned APG Seven that its supplement labels claim to treat cancer, diabetes and other diseases, making them unapproved new drugs.

    High risk
  41. Bodywell Natural Skin Care Inc.

    FDA warned Bodywell Natural Skin Care that its OTC hand sanitizer and Dermalere creams were adulterated due to CGMP failures and unapproved drug claims.

    High risk
  42. Ambaya Gold Health Products, LLC

    FDA warned Ambaya Gold Health Products that website and social media claims made its supplements and silver products unapproved new drugs.

    High risk
  43. Sky Bank Media, LLC dba Painless Tattoo Cream Co.

    FDA warned Painless Tattoo Cream Co. that its numbing cream and spray are unapproved new drugs with excess lidocaine.

    High risk
  44. Dermal Source, Inc.

    FDA warned Dermal Source that five topical anesthetic products are unapproved and misbranded drugs with lidocaine above OTC limits.

    High risk
  45. SeeNext Venture, Ltd.

    FDA warns SeeNext Venture over unapproved, misbranded NumbSkin lidocaine creams sold online.

    High risk
  46. TKTX Company

    TKTX Company sells unapproved, misbranded lidocaine numbing creams online at illegal concentrations for cosmetic procedures.

    High risk
  47. Indelicare DBA INKEEZE

    FDA warns Indelicare that its INKEEZE lidocaine numbing gel, spray and foam soap are unapproved new drugs sold outside OTC limits.

    High risk
  48. Ammonia Sport Inc.

    Ammonia Sport Inc. sells three smelling-salt stimulant drugs as unapproved new drugs and misbranded products, FDA says.

    High risk
  49. Skull Smash LLC

    Skull Smash LLC sold unapproved, misbranded ammonia inhalant stimulant drugs online, FDA says.

    High risk
  50. Spirochaete Research Labs, LLC aka Scitus Laboratory Products

    FDA warned Spirochaete Research Labs that its Atomic Rhino smelling-salt products are unapproved and misbranded stimulant drugs.

    High risk